So You Want To Make A Biosimilar: Top Considerations Before BLA Submission

Developing and successfully commercializing a biosimilar is a complex and expensive process. This webinar provides a broad overview of important strategic considerations that biosimilar makers should take into account before submitting an aBLA to increase the odds of a successful launch. Topics that will be covered include the 271(e) Safe Harbor, peremptory challenges, labelling and timing considerations, and competitive intelligence.

Naomi Birbach, Josh Weinger, and Alison Siedor will host this webinar.

CLE credit will be offered for California, Minnesota, New Jersey, New York and Pennsylvania.